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Continuous real-time monitoring of left ventricular 
%jection fraction WEF) would be highly ra-1ewar.t to the 
study of acutely ill patients. C ~rently~ LVEF can be 
continuously recorded over sever 1 hours using the VEST 
system. However, analysis can on y Zie perforxned off-line 
after the completion of data acquisition. This precludes 
real-rim@ recognition of changes in LVEF, s phenomenon 
that would have substantial research potential and 
clinical applicability. An on-line portable 
microprocessor (EF meter) has been developed to display 
and record real-time continuous LVEF using the VEST 
detector. In order to validate the ability of the EF 
meter to track LVEF continuously during myocardial 
ischemia, 7 pts were studied during ball?oa occlusion 
while undergoing coronary angio lasty WTCW). 11 balloon 
inflations were monitored and r corded with .ooCh EF meter 
and VEST. There was excellent agreement of LVEF 
calculated with both techniques over a wide range of EF 
(0.19-O.G7, r=0.96). Baseline LVEF was 0.50f0.09 with the 
VEST and 0.52f0.09 with the EF meter (p NS); at maximal 
LV dysfunction, LVEF was 0.32x0.13 with the VEST and 
0.30f0.14 with the EF meter (p-0.05). The time to OnSet 
and recovery of LV dysfunstian during PTCA were the Same 
for both techniques. 
Thus, the EF nwter is able to celculate rind display 
real-time LVEF accurately over a broad range of ejection 
fractions. This technique could provide immkediste 
recognition of changes in LVEF thereby offering a new 
dimension for the investigation and clinical recognition 
of acute coronary syndromes. 
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